New Zealand markets close in 6 hours 29 minutes

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.9300-0.2000 (-4.84%)
At close: 04:00PM EST
3.9700 +0.04 (+1.02%)
After hours: 07:54PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
72,684
227,547
148,364
0
Cost of revenue
10,830
2,392
-
-
Gross profit
61,854
225,155
-
-
Operating expenses
Research development
120,323
146,936
175,611
171,488
Selling general and administrative
208,202
199,615
65,854
33,097
Total operating expenses
328,525
346,551
241,465
204,585
Operating income or loss
-266,671
-121,396
-93,101
-204,585
Interest expense
41,854
22,670
8,120
100
Total other income/expenses net
60
515
4,056
2,875
Income before tax
-308,465
-143,551
-97,165
-201,810
Income from continuing operations
-308,465
-143,551
-97,165
-201,810
Net income
-308,465
-143,551
-97,165
-201,810
Net income available to common shareholders
-308,465
-143,551
-97,165
-201,810
Basic EPS
-
-5.23
-3.59
-7.54
Diluted EPS
-
-5.23
-3.59
-7.54
Basic average shares
-
27,474
27,090
26,754
Diluted average shares
-
27,474
27,090
26,754
EBITDA
-
-120,334
-88,726
-201,445